Persistent Dentoalveolar Pain After Root Canal Therapy
A 48-year-old woman presents with a 2-year history of continuous, deep, aching pain in the right mandibular first molar region. She has undergone two root canal retreatments and one apicoectomy, all with no relief. The tooth was eventually extracted 6 months ago, but the pain persists unchanged in the same location. She describes the pain as 7/10, constant, with occasional sharp jabs. She has allodynia to light touch over the right cheek. She is otherwise healthy, takes no medications, and has no history of trauma. Examination shows a well-healed extraction site, no swelling, no lymphadenopathy, and normal panoramic radiograph. Neurologic exam reveals decreased pinprick sensation in the right V3 distribution.
1. What is the most likely diagnosis, and what key features support it?
Read the worked answer
The most likely diagnosis is persistent idiopathic dentoalveolar pain (PIDAP) (also known as atypical odontalgia) or painful post-traumatic trigeminal neuropathy (PPTTN). The key features supporting a neuropathic mechanism include: (1) pain persists after extraction and multiple failed dental interventions, (2) the pain is continuous and described as deep and aching with sharp jabs, (3) there is allodynia and decreased pinprick sensation in the V3 distribution, indicating nerve injury, and (4) imaging and clinical exam show no ongoing peripheral pathology. The history of multiple root canal treatments and apicoectomy likely caused or contributed to nerve injury. PIDAP is a diagnosis of exclusion, but the presence of sensory changes strongly suggests a neuropathic component. The lack of response to dental treatment further supports a non-odontogenic cause.
2. Outline a management plan, including pharmacologic and non-pharmacologic options, and explain the rationale.
Read the worked answer
Management should be multidisciplinary and symptom-based. First, avoid further irreversible dental treatments. Pharmacologically, consider a trial of a tricyclic antidepressant (e.g., amitriptyline 10–25 mg at bedtime) or a serotonin-norepinephrine reuptake inhibitor (e.g., duloxetine 30 mg daily, titrated to 60 mg) for neuropathic pain. Alternatively, gabapentin or pregabalin may be used, but evidence in PIDAP is limited. Topical agents such as lidocaine 5% patch or capsaicin cream may help if allodynia is prominent. Non-pharmacologically, cognitive-behavioral therapy (CBT) can address pain catastrophizing and improve coping. A pain specialist or orofacial pain specialist should be involved. Regular follow-up to monitor response and side effects is essential. Patient education about the nature of neuropathic pain and realistic expectations is crucial. Avoid opioids. If symptoms persist, consider referral to a tertiary pain center for advanced therapies (e.g., sympathetic blocks, though evidence is weak).